Submitted May 10, 2007
Finding Fosamax Lawyers
Fosamax® was recently shown to have a higher incidence of ONJ than other bisphosphonates in a study conducted by the U.S. Food and Drug Administration. Additionally, evidence suggests that Merck failed to update the Fosamax® label to reflect the danger.